CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy
Authors
Keywords
Pharmacogenetics, <em class=EmphasisTypeItalic >CYP2B6</em> gene, <em class=EmphasisTypeItalic >ANKK1</em> gene, Bupropion
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 71, Issue 9, Pages 1067-1073
Publisher
Springer Nature
Online
2015-07-07
DOI
10.1007/s00228-015-1896-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP2B6Gene Single-Nucleotide Polymorphisms in an Italian Population Sample and Relationship with Nicotine Dependence
- (2015) Laura Natalia Riccardi et al. Genetic Testing and Molecular Biomarkers
- Implementation of effective cigarette health warning labels among low and middle income countries: State capacity, path-dependency and tobacco industry activity
- (2015) Heikki Hiilamo et al. SOCIAL SCIENCE & MEDICINE
- Smoking cessation and weight gain in patients with cardiovascular disease or risk factor
- (2014) Jaqueline S. Issa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Efficacy of Varenicline Combined With Nicotine Replacement Therapy vs Varenicline Alone for Smoking Cessation
- (2014) Coenraad F. N. Koegelenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A survey of tobacco dependence treatment services in 121 countries
- (2013) Hembadoon Piné-Abata et al. ADDICTION
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
- (2013) Ulrich M. Zanger et al. Frontiers in Genetics
- Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey
- (2012) Karin A. Kasza et al. ADDICTION
- CYP2B6 and Bupropion’s Smoking-Cessation Pharmacology: The Role of Hydroxybupropion
- (2012) A Z X Zhu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effectiveness of Coadministration of Varenicline, Bupropion, and Serotonin Reuptake Inhibitors in a Smoking Cessation Program in the Real-Life Setting
- (2012) Jaqueline S. Issa et al. NICOTINE & TOBACCO RESEARCH
- CYP2C19 and ABCB1gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
- (2011) Paulo CJL Santos et al. BMC Medical Genetics
- SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group
- (2011) Paulo CJL Santos et al. BMC Medical Genetics
- Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex
- (2011) H. Zhang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- ‘Smoking Genes’: A Genetic Association Study
- (2011) Zoraida Verde et al. PLoS One
- Efavirenz in the therapy of HIV infection
- (2009) Natella Y Rakhmanina et al. Expert Opinion on Drug Metabolism & Toxicology
- Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers
- (2009) Doug-Hyun Han et al. PSYCHIATRIC GENETICS
- A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update
- (2008) AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver
- (2008) M. H. Hofmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacogenetics of Anti-HIV Drugs
- (2007) A. Telenti et al. Annual Review of Pharmacology and Toxicology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More